XML 36 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Investments and Derivative Instruments Level 3 (Tables)
3 Months Ended
Mar. 31, 2015
Investments [Abstract]  
Net Realized Capital Gains (Losses)
Net Realized Capital Gains (Losses)
 
Three Months Ended March 31,
(Before tax)
2015
2014
Gross gains on sales
$
197

$
183

Gross losses on sales
(148
)
(129
)
Net OTTI losses recognized in earnings
(12
)
(22
)
Valuation allowances on mortgage loans
(3
)

Periodic net coupon settlements on credit derivatives
1

(1
)
Results of variable annuity hedge program


GMWB derivatives, net
1

15

Macro hedge program
(4
)
(10
)
Total results of variable annuity hedge program
(3
)
5

Other, net [1]
(27
)
(71
)
Net realized capital gains
$
5

$
(35
)

[1]
Primarily consists of changes in the value of non-qualifying derivatives, transactional foreign currency revaluation gains (losses) on the Japan fixed payout annuity liabilities assumed from HLIKK and gains (losses) on non-qualifying derivatives used to hedge the foreign currency exposure of the liabilities. For the three months ended March 31, 2015 and 2014, gains (losses) from transactional foreign currency revaluation of the Japan fixed payout annuity liabilities were $0 and $(28), respectively. For the three months ended March 31, 2015 and 2014, gains (losses) on instruments used to hedge the foreign currency exposure on the fixed payout annuities were $(14) and $15, respectively.
Other-Than-Temporary Impairment Losses
Recognition and Presentation of Other-Than-Temporary Impairments
The Company deems bonds and certain equity securities with debt-like characteristics (collectively “debt securities”) to be other-than-temporarily impaired (“impaired”) if a security meets the following conditions: a) the Company intends to sell or it is more likely than not that the Company will be required to sell the security before a recovery in value, or b) the Company does not expect to recover the entire amortized cost basis of the security. If the Company intends to sell or it is more likely than not that the Company will be required to sell the security before a recovery in value, a charge is recorded in net realized capital losses equal to the difference between the fair value and amortized cost basis of the security. For those impaired debt securities which do not meet the first condition and for which the Company does not expect to recover the entire amortized cost basis, the difference between the security’s amortized cost basis and the fair value is separated into the portion representing a credit OTTI, which is recorded in net realized capital losses, and the remaining non-credit impairment, which is recorded in OCI. Generally, the Company determines a security’s credit impairment as the difference between its amortized cost basis and its best estimate of expected future cash flows discounted at the security’s effective yield prior to impairment. The remaining non-credit impairment is the difference between the security’s fair value and the Company’s best estimate of expected future cash flows discounted at the security’s effective yield prior to the impairment, which typically represents current market liquidity and risk premiums. The previous amortized cost basis less the impairment recognized in net realized capital losses becomes the security’s new cost basis. The Company accretes the new cost basis to the estimated future cash flows over the expected remaining life of the security by prospectively adjusting the security’s yield, if necessary.
The Company’s evaluation of whether a credit impairment exists for debt securities includes but is not limited to, the following factors: (a) changes in the financial condition of the security’s underlying collateral, (b) whether the issuer is current on contractually obligated interest and principal payments, (c) changes in the financial condition, credit rating and near-term prospects of the issuer, (d) the extent to which the fair value has been less than the amortized cost of the security and (e) the payment structure of the security. The Company’s best estimate of expected future cash flows used to determine the credit loss amount is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the security. The Company’s best estimate of future cash flows involves assumptions including, but not limited to, various performance indicators, such as historical and projected default and recovery rates, credit ratings, current and projected delinquency rates, and loan-to-value ("LTV") ratios. In addition, for structured securities, the Company considers factors including, but not limited to, average cumulative collateral loss rates that vary by vintage year, commercial and residential property value declines that vary by property type and location and commercial real estate delinquency levels. These assumptions require the use of significant management judgment and include the probability of issuer default and estimates regarding timing and amount of expected recoveries which may include estimating the underlying collateral value. In addition, projections of expected future debt security cash flows may change based upon new information regarding the performance of the issuer and/or underlying collateral such as changes in the projections of the underlying property value estimates.
For equity securities where the decline in the fair value is deemed to be other-than-temporary, a charge is recorded in net realized capital losses equal to the difference between the fair value and cost basis of the security. The previous cost basis less the impairment becomes the security’s new cost basis. The Company asserts its intent and ability to retain those equity securities deemed to be temporarily impaired until the price recovers. Once identified, these securities are systematically restricted from trading unless approved by investment and accounting professionals. The investment and accounting professionals will only authorize the sale of these securities based on predefined criteria that relate to events that could not have been reasonably foreseen. Examples of the criteria include, but are not limited to, the deterioration in the issuer’s financial condition, security price declines, a change in regulatory requirements or a major business combination or major disposition.
The primary factors considered in evaluating whether an impairment exists for an equity security include, but are not limited to: (a) the length of time and extent to which the fair value has been less than the cost of the security, (b) changes in the financial condition, credit rating and near-term prospects of the issuer, (c) whether the issuer is current on preferred stock dividends and (d) the intent and ability of the Company to retain the investment for a period of time sufficient to allow for recovery.
Impairments for the three months ended March 31, 2015 and 2014 were $12 and $22, respectively. Impairments for the three months ended March 31, 2015 primarily consisted of securities in an unrealized loss which the Company had the intent-to-sell. Impairments for the three months ended March 31, 2014 primarily consisted of credit impairments caused by issuer specific deterioration.
The following table presents a roll-forward of the Company’s cumulative credit impairments on debt securities held.
 
Three Months Ended March 31,
(Before-tax)
2015
2014
Balance as of beginning of period
$
(424
)
$
(552
)
Additions for credit impairments recognized on [1]:


Securities not previously impaired
(3
)
(7
)
Securities previously impaired

(11
)
Reductions for credit impairments previously recognized on:


Securities that matured or were sold during the period
4

33

Securities the Company made the decision to sell or more likely than not will be required to sell
2


Securities due to an increase in expected cash flows
9

6

Balance as of end of period
$
(412
)
$
(531
)
[1]
These additions are included in the net OTTI losses recognized in earnings in the Condensed Consolidated Statements of Operations.
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]
Available-for-Sale Securities
The following table presents the Company’s AFS securities by type.
 
March 31, 2015
 
December 31, 2014
 
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Non-Credit
OTTI [1]
 
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Non-Credit
OTTI [1]
ABS
$
2,997

$
41

$
(34
)
$
3,004

$

 
$
2,470

$
39

$
(37
)
$
2,472

$
(1
)
CDOs [2]
2,891

115

(22
)
2,982


 
2,776

98

(36
)
2,841


CMBS
4,445

223

(16
)
4,652

(7
)
 
4,235

196

(16
)
4,415

(6
)
Corporate
24,698

2,558

(137
)
27,119

(6
)
 
25,188

2,382

(211
)
27,359

(3
)
Foreign govt./govt. agencies
1,310

69

(14
)
1,365


 
1,592

73

(29
)
1,636


Municipal
11,656

1,189

(3
)
12,842


 
11,735

1,141

(5
)
12,871


RMBS
3,963

132

(17
)
4,078

(1
)
 
3,815

122

(19
)
3,918

(1
)
U.S. Treasuries
4,144

371

(2
)
4,513


 
3,551

326

(5
)
3,872


Total fixed maturities, AFS
56,104

4,698

(245
)
60,555

(14
)
 
55,362

4,377

(358
)
59,384

(11
)
Equity securities, AFS [3]
726

48

(28
)
746


 
676

50

(27
)
699


Total AFS securities
$
56,830

$
4,746

$
(273
)
$
61,301

$
(14
)
 
$
56,038

$
4,427

$
(385
)
$
60,083

$
(11
)
[1]
Represents the amount of cumulative non-credit OTTI losses recognized in OCI on securities that also had credit impairments. These losses are included in gross unrealized losses as of March 31, 2015 and December 31, 2014.
[2]
Gross unrealized gains (losses) exclude the fair value of bifurcated, embedded derivative features of certain securities. Subsequent changes in value are recorded in net realized capital gains (losses).
[3]
Excludes equity securities, FVO, with a cost and fair value of $403 and $402, respectively, as of March 31, 2015, and $351 and $348, respectively, as of December 31, 2014.
Investments Classified by Contractual Maturity Date [Table Text Block]
The following table presents the Company’s fixed maturities, AFS, by contractual maturity year.
 
March 31, 2015
December 31, 2014
Contractual Maturity
Amortized Cost
Fair Value
Amortized Cost
Fair Value
One year or less
$
1,832

$
1,856

$
2,141

$
2,168

Over one year through five years
11,883

12,446

11,264

11,827

Over five years through ten years
8,778

9,294

8,802

9,226

Over ten years
19,315

22,243

19,859

22,517

Subtotal
41,808

45,839

42,066

45,738

Mortgage-backed and asset-backed securities
14,296

14,716

13,296

13,646

Total fixed maturities, AFS
$
56,104

$
60,555

$
55,362

$
59,384

Unrealized Loss Aging on AFS Securities [Table Text Block]
 
March 31, 2015
 
Less Than 12 Months
 
12 Months or More
 
Total
 
Amortized Cost
Fair Value
Unrealized Losses
 
Amortized Cost
Fair Value
Unrealized Losses
 
Amortized Cost
Fair Value
Unrealized Losses
ABS
$
736

$
735

$
(1
)
 
$
416

$
383

$
(33
)
 
$
1,152

$
1,118

$
(34
)
CDOs [1]
593

591

(2
)
 
1,341

1,319

(20
)
 
1,934

1,910

(22
)
CMBS
233

230

(3
)
 
192

179

(13
)
 
425

409

(16
)
Corporate
2,086

2,022

(64
)
 
710

637

(73
)
 
2,796

2,659

(137
)
Foreign govt./govt. agencies
251

244

(7
)
 
118

111

(7
)
 
369

355

(14
)
Municipal
169

167

(2
)
 
33

32

(1
)
 
202

199

(3
)
RMBS
717

714

(3
)
 
277

263

(14
)
 
994

977

(17
)
U.S. Treasuries
245

244

(1
)
 
62

61

(1
)
 
307

305

(2
)
Total fixed maturities, AFS
5,030

4,947

(83
)
 
3,149

2,985

(162
)
 
8,179

7,932

(245
)
Equity securities, AFS [2]
198

185

(13
)
 
108

93

(15
)
 
306

278

(28
)
Total securities in an unrealized loss position
$
5,228

$
5,132

$
(96
)
 
$
3,257

$
3,078

$
(177
)
 
$
8,485

$
8,210

$
(273
)
 
December 31, 2014
 
Less Than 12 Months
 
12 Months or More
 
Total
 
Amortized Cost
Fair Value
Unrealized Losses
 
Amortized Cost
Fair Value
Unrealized Losses
 
Amortized Cost
Fair Value
Unrealized Losses
ABS
$
897

$
893

$
(4
)
 
$
473

$
440

$
(33
)
 
$
1,370

$
1,333

$
(37
)
CDOs [1]
748

743

(5
)
 
1,489

1,461

(31
)
 
2,237

2,204

(36
)
CMBS
230

227

(3
)
 
319

306

(13
)
 
549

533

(16
)
Corporate
3,082

2,980

(102
)
 
1,177

1,068

(109
)
 
4,259

4,048

(211
)
Foreign govt./govt. agencies
363

349

(14
)
 
227

212

(15
)
 
590

561

(29
)
Municipal
74

73

(1
)
 
86

82

(4
)
 
160

155

(5
)
RMBS
320

318

(2
)
 
433

416

(17
)
 
753

734

(19
)
U.S. Treasuries
432

431

(1
)
 
361

357

(4
)
 
793

788

(5
)
Total fixed maturities, AFS
6,146

6,014

(132
)
 
4,565

4,342

(226
)
 
10,711

10,356

(358
)
Equity securities, AFS [2]
172

160

(12
)
 
102

87

(15
)
 
274

247

(27
)
Total securities in an unrealized loss position
$
6,318

$
6,174

$
(144
)
 
$
4,667

$
4,429

$
(241
)
 
$
10,985

$
10,603

$
(385
)
[1]
Unrealized losses exclude the change in fair value of bifurcated embedded derivative features of certain securities, for which changes in fair value are recorded in net realized capital gains (losses).
Mortgage Loans [Table Text Block]
 
March 31, 2015
 
December 31, 2014
 
Amortized Cost [1]
Valuation Allowance
Carrying Value
 
Amortized Cost [1]
Valuation Allowance
Carrying Value
Total commercial mortgage loans
$
5,718

$
(21
)
$
5,697

 
$
5,574

$
(18
)
$
5,556

[1]
Amortized cost represents carrying value prior to valuation allowances, if any.
Valuation Allowance for Mortgage Loans [Table Text Block]
 
2015
2014
Balance, as of January 1
$
(18
)
$
(67
)
(Additions)/Reversals
(3
)

Deductions

50

Balance, as of March 31
$
(21
)
$
(17
)
Commercial Mortgage Loans Credit Quality [Table Text Block]
The following table presents the carrying value of the Company’s commercial mortgage loans by LTV and DSCR.
Commercial Mortgage Loans Credit Quality
 
March 31, 2015
 
December 31, 2014
Loan-to-value
Carrying Value
Avg. Debt-Service Coverage Ratio
 
Carrying Value
Avg. Debt-Service Coverage Ratio
Greater than 80%
$
49

1.12x
 
$
53

1.07x
65% - 80%
928

1.73x
 
789

1.75x
Less than 65%
4,720

2.69x
 
4,714

2.66x
Total commercial mortgage loans
$
5,697

2.51x
 
$
5,556

2.51x
Mortgage Loans by Region [Table Text Block]
The following tables present the carrying value of the Company’s mortgage loans by region and property type.
Mortgage Loans by Region
 
March 31, 2015
 
December 31, 2014
 
Carrying Value
Percent of Total
 
Carrying Value
Percent of Total
East North Central
$
231

4.1
%
 
$
211

3.8
%
Middle Atlantic
452

7.9
%
 
468

8.4
%
Mountain
88

1.5
%
 
88

1.6
%
New England
381

6.7
%
 
381

6.9
%
Pacific
1,646

28.9
%
 
1,607

29.0
%
South Atlantic
1,104

19.4
%
 
1,019

18.3
%
West North Central
44

0.8
%
 
44

0.8
%
West South Central
319

5.6
%
 
302

5.4
%
Other [1]
1,432

25.1
%
 
1,436

25.8
%
Total mortgage loans
$
5,697

100.0
%
 
$
5,556

100.0
%
[1]
Primarily represents loans collateralized by multiple properties in various regions.
Mortgage Loans by Property Type [Table Text Block]
Mortgage Loans by Property Type
 
March 31, 2015
 
December 31, 2014
 
Carrying Value
Percent of Total
 
Carrying
Value
Percent of Total
Commercial
 
 
 
 
 
Agricultural
$
46

0.8
%
 
$
46

0.8
%
Industrial
1,465

25.7
%
 
1,476

26.6
%
Lodging
26

0.5
%
 
26

0.5
%
Multifamily
1,267

22.2
%
 
1,190

21.4
%
Office
1,538

27.0
%
 
1,517

27.3
%
Retail
1,204

21.1
%
 
1,147

20.6
%
Other
151

2.7
%
 
154

2.8
%
Total mortgage loans
$
5,697

100.0
%
 
$
5,556

100.0
%
Schedule of Variable Interest Entities [Table Text Block]
 
March 31, 2015
 
December 31, 2014
 
Total Assets
Total Liabilities [1]
Maximum Exposure to Loss [2]
 
Total Assets
Total Liabilities [1]
Maximum Exposure to Loss [2]
CDOs [3]
$
5

$
5

$

 
$
5

$
5

$

Investment funds [4]
232


235

 
238


243

Limited partnerships and other alternative investments
2


2

 
3

1

2

Total
$
239

$
5

$
237

 
$
246

$
6

$
245

[1]
Included in other liabilities in the Company’s Condensed Consolidated Balance Sheets.
[2]
The maximum exposure to loss represents the maximum loss amount that the Company could recognize as a reduction in net investment income or as a realized capital loss and is the cost basis of the Company’s investment.
[3]
Total assets included in cash in the Company’s Condensed Consolidated Balance Sheets.
[4]
Total assets included in fixed maturities, FVO, short-term investments, equity, AFS, and cash in the Company’s Condensed Consolidated Balance Sheets.
Derivative Instruments [Abstract]  
Notional and Fair Value for GMWB Hedging Instruments [Table Text Block]
 
Notional Amount
 
Fair Value
 
March 31,
2015
December 31, 2014
 
March 31,
2015
December 31, 2014
Customized swaps
$
6,806

$
7,041

 
$
144

$
124

Equity swaps, options, and futures
1,803

3,761

 
11

39

Interest rate swaps and futures
3,570

3,640

 
26

11

Total
$
12,179

$
14,442

 
$
181

$
174

Notional and Fair Value for Macro Hedge Program [Table Text Block]
Macro hedge program
The Company utilizes equity options, swaps, futures, and foreign currency options to partially hedge against a decline in the equity markets and the resulting statutory surplus and capital impact primarily arising from the guaranteed minimum death benefit ("GMDB") and GMWB obligations. The following table presents notional and fair value for the macro hedge program.
 
Notional Amount
 
Fair Value
 
March 31,
2015
December 31, 2014
 
March 31,
2015
December 31, 2014
Equity swaps, options, and futures
7,342

5,983

 
187

141

Foreign currency options
400

400

 


Total
$
7,742

$
6,383

 
$
187

$
141

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
 
Net Derivatives
 
Asset Derivatives
 
Liability Derivatives
 
Notional Amount
 
Fair Value
 
Fair Value
 
Fair Value
Hedge Designation/ Derivative Type
Mar. 31, 2015
Dec. 31, 2014
 
Mar. 31, 2015
Dec. 31, 2014
 
Mar. 31, 2015
Dec. 31, 2014
 
Mar. 31, 2015
Dec. 31, 2014
Cash flow hedges
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
$
4,001

$
3,999

 
$
100

$
44

 
$
101

$
52

 
$
(1
)
$
(8
)
Foreign currency swaps
143

143

 
(27
)
(19
)
 
6

3

 
(33
)
(22
)
Total cash flow hedges
4,144

4,142

 
73

25

 
107

55

 
(34
)
(30
)
Fair value hedges
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
66

32

 


 


 


Total fair value hedges
66

32

 


 


 


Non-qualifying strategies
 
 
 
 
 
 
 
 
 
 
 
Interest rate contracts
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps and futures
15,295

15,254

 
(501
)
(512
)
 
718

536

 
(1,219
)
(1,048
)
Foreign exchange contracts
 
 
 
 
 
 
 
 
 
 
 
Foreign currency swaps and forwards
179

177

 
8

1

 
9

3

 
(1
)
(2
)
Japan fixed payout annuity hedge
1,319

1,319

 
(441
)
(427
)
 


 
(441
)
(427
)
Credit contracts
 
 
 
 
 
 
 
 
 
 
 
Credit derivatives that purchase credit protection
197

595

 
(3
)
(6
)
 

4

 
(3
)
(10
)
Credit derivatives that assume credit risk [1]
1,863

1,487

 
8

3

 
21

14

 
(13
)
(11
)
Credit derivatives in offsetting positions
5,150

5,343

 
(3
)
(3
)
 
49

53

 
(52
)
(56
)
Equity contracts
 
 
 
 
 
 
 
 
 
 
 
Equity index swaps and options
541

635

 
4

2

 
34

31

 
(30
)
(29
)
Commodity contracts
 
 
 
 
 
 
 
 
 
 
 
Commodity options
582


 
10


 
10


 


Variable annuity hedge program
 
 
 
 
 
 
 
 
 
 
 
GMWB product derivatives [2]
17,079

17,908

 
(176
)
(139
)
 


 
(176
)
(139
)
GMWB reinsurance contracts
3,514

3,659

 
65

56

 
65

56

 


GMWB hedging instruments
12,179

14,442

 
181

174

 
309

289

 
(128
)
(115
)
Macro hedge program
7,742

6,383

 
187

141

 
227

180

 
(40
)
(39
)
Other
 
 
 
 
 
 
 
 
 
 
 
Contingent capital facility put option
500

500

 
11

12

 
11

12

 


Modified coinsurance reinsurance contracts
963

974

 
22

34

 
22

34

 


Total non-qualifying strategies
67,103

68,676

 
(628
)
(664
)
 
1,475

1,212

 
(2,103
)
(1,876
)
Total cash flow hedges, fair value hedges, and non-qualifying strategies
$
71,313

$
72,850

 
$
(555
)
$
(639
)
 
$
1,582

$
1,267

 
$
(2,137
)
$
(1,906
)
Balance Sheet Location
 
 
 
 
 
 
 
 
 
 
 
Fixed maturities, available-for-sale
$
454

$
454

 
$
(2
)
$
2

 
$

$
2

 
$
(2
)
$

Other investments
22,729

23,014

 
445

364

 
659

624

 
(214
)
(260
)
Other liabilities
26,524

26,791

 
(883
)
(930
)
 
836

551

 
(1,719
)
(1,481
)
Reinsurance recoverables
4,477

4,633

 
87

90

 
87

90

 


Other policyholder funds and benefits payable
17,129

17,958

 
(202
)
(165
)
 


 
(202
)
(165
)
Total derivatives
$
71,313

$
72,850

 
$
(555
)
$
(639
)
 
$
1,582

$
1,267

 
$
(2,137
)
$
(1,906
)
[1]
The derivative instruments related to this strategy are held for other investment purposes.
[2]
These derivatives are embedded within liabilities and are not held for risk management purposes.
Offsetting Assets and Liabilities [Table Text Block]
The following tables present the gross fair value amounts, the amounts offset, and net position of derivative instruments eligible for offset in the Company's Condensed Consolidated Balance Sheets. Amounts offset include fair value amounts, income accruals and related cash collateral receivables and payables associated with derivative instruments that are traded under a common master netting agreement, as described in the preceding discussion. Also included in the tables are financial collateral receivables and payables, which are contractually permitted to be offset upon an event of default, although are disallowed for offsetting under U.S. GAAP.
As of March 31, 2015
 
(i)
 
(ii)
 
(iii) = (i) - (ii)
(iv)
 
(v) = (iii) - (iv)
 
 
 
 
 
Net Amounts Presented in the Statement of Financial Position
 
Collateral Disallowed for Offset in the Statement of Financial Position
 
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Statement of Financial Position
 
Derivative Assets [1]
 
Accrued Interest and Cash Collateral Received [2]
 
Financial Collateral Received [4]
 
Net Amount
Description
 
 
 
 
 
 
 
 
 
 
 
Other investments
$
1,495

 
$
1,268

 
$
445

 
$
(218
)
 
$
138

 
$
89

 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Statement of Financial Position
 
Derivative Liabilities [3]
 
Accrued Interest and Cash Collateral Pledged [3]
 
Financial Collateral Pledged [4]
 
Net Amount
Description
 
 
 
 
 
 
 
 
 
 
 
Other liabilities
$
(1,933
)
 
$
(946
)
 
$
(880
)
 
$
(107
)
 
$
(1,131
)
 
$
144

As of December 31, 2014
 
(i)
 
(ii)
 
(iii) = (i) - (ii)
(iv)
 
(v) = (iii) - (iv)
 
 
 
 
 
Net Amounts Presented in the Statement of Financial Position
 
Collateral Disallowed for Offset in the Statement of Financial Position
 
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Statement of Financial Position
 
Derivative Assets [1]
 
Accrued Interest and Cash Collateral Received [2]
 
Financial Collateral Received [4]
 
Net Amount
Description
 
 
 
 
 
 
 
 
 
 
 
Other investments
$
1,175

 
$
969

 
$
364

 
$
(158
)
 
$
109

 
$
97

 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Statement of Financial Position
 
Derivative Liabilities [3]
 
Accrued Interest and Cash Collateral Pledged [3]
 
Financial Collateral Pledged [4]
 
Net Amount
Description
 
 
 
 
 
 
 
 
 
 
 
Other liabilities
$
(1,741
)
 
$
(799
)
 
$
(927
)
 
$
(15
)
 
$
(1,079
)
 
$
137

[1]
Included in other invested assets in the Company's Condensed Consolidated Balance Sheets.
[2]
Included in other assets in the Company's Condensed Consolidated Balance Sheets and is limited to the net derivative receivable associated with each counterparty.
[3]
Included in other liabilities in the Company's Condensed Consolidated Balance Sheets and is limited to the net derivative payable associated with each counterparty. Not included in this amount are embedded derivatives associated with consumer notes of $(3) as of March 31, 2015 and December 31, 2014, which were not eligible for offset in the Company's Condensed Consolidated Balance Sheets.
[4]
Excludes collateral associated with exchange-traded derivative instruments.
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]
Derivatives in Cash Flow Hedging Relationships
 
Gain (Loss) Recognized in OCI on Derivative (Effective Portion)
Net Realized Capital Gains(Losses) Recognized in Income on Derivative (Ineffective Portion)
 
Three Months Ended March 31,
Three Months Ended March 31,
 
2015
2014
2015
2014
Interest rate swaps
$
56

$
44

$

$
(1
)
Foreign currency swaps
(7
)
(1
)


Total
$
49

$
43

$

$
(1
)
 
 
Gain or (Loss) Reclassified from AOCI into Income (Effective Portion)
 
 
Three Months Ended March 31,
 
Location
2015
2014
Interest rate swaps
Net realized capital gain (loss)
$
1

$
1

Interest rate swaps
Net investment income
16

23

Foreign currency swaps
Net realized capital gain (loss)
(10
)

Total
 
$
7

$
24

Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]
rivatives in Fair Value Hedging Relationships
 
 
Gain or (Loss) Recognized in Income [1]
 
 
Three Months Ended March 31,
 
 
2015
 
2014
 
Location
Derivative
Hedge Item
 
Derivative
Hedge Item
Interest rate swaps
Net realized capital gain/(loss)
$

$

 
$
(1
)
$

[1]
The amounts presented do not include the periodic net coupon settlements of the derivative or the coupon income (expense) related to the hedged item. The net of the amounts presented represents the ineffective portion of the hedge.
Gain or Loss Recognized with in Net Realized Capital Gains Losses on Non Qualifying Strategies [Table Text Block]
Derivatives Used in Non-Qualifying Strategies
Gain or (Loss) Recognized within Net Realized Capital Gains and Losses
 
Three Months Ended March 31,
 
2015
2014
Interest rate contracts
 
 
Interest rate swaps and forwards
$
(12
)
$
(57
)
Foreign exchange contracts
 
 
Foreign currency swaps and forwards
7

(2
)
Japan fixed payout annuity hedge [1]
(14
)
15

Credit contracts
 
 
Credit derivatives that purchase credit protection
(2
)
(4
)
Credit derivatives that assume credit risk
9

(1
)
Equity contracts
 
 
Equity index swaps and options
(3
)

Commodity contracts
 
 
Commodity options
(5
)

Variable annuity hedge program
 
 
GMWB product derivatives
(19
)
36

GMWB reinsurance contracts
7

(4
)
GMWB hedging instruments
13

(17
)
Macro hedge program
(4
)
(10
)
Other
 
 
Contingent capital facility put option
(2
)
(1
)
Modified coinsurance reinsurance contracts
(11
)
(19
)
Total [2]
$
(36
)
$
(64
)
[1]
Not included in this amount is the associated liability adjustment for changes in foreign exchange spot rates through realized capital gains of $0 and $(28) for the three months ended March 31, 2015 and 2014, respectively.
[2]
Excludes investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 4 - Fair Value Measurements.
Disclosure of Credit Derivatives [Table Text Block]
As of March 31, 2015
 
 
 
 
Underlying Referenced Credit
Obligation(s) [1]
 
 
Credit Derivative type by derivative risk exposure
Notional
Amount
[2]
Fair
Value
Weighted
Average
Years to
Maturity
Type
Average
Credit
Rating
Offsetting
Notional
Amount [3]
Offsetting
Fair
Value [3]
Single name credit default swaps
 
 
 
 
 
 
 
Investment grade risk exposure
$
252

$
4

2 years
Corporate Credit/
Foreign Gov.
BBB+
$
227

$
(4
)
Below investment grade risk exposure
29


2 years
Corporate Credit
BB
29

(1
)
Basket credit default swaps [4]
 
 
 
 
 
 
 
Investment grade risk exposure
2,721

38

3 years
Corporate Credit
BBB+
1,898

(23
)
Below investment grade risk exposure
59

4

5 years
Corporate Credit
B+


Investment grade risk exposure
873

(12
)
6 years
CMBS Credit
AA+
267

2

Below investment grade risk exposure
154

(22
)
2 years
CMBS Credit
CCC+
154

21

Embedded credit derivatives
 
 
 
 
 
 
 
Investment grade risk exposure
350

347

2 years
Corporate Credit
A+


Total [5]
$
4,438

$
359

 
 
 
$
2,575

$
(5
)
As of December 31, 2014
 
 
 
 
Underlying Referenced
Credit Obligation(s) [1]
 
 
Credit Derivative type by derivative risk exposure
Notional
Amount [2]
Fair
Value
Weighted
Average
Years to
Maturity
Type
Average
Credit
Rating
Offsetting
Notional
Amount [3]
Offsetting
Fair
Value [3]
Single name credit default swaps
 
 
 
 
 
 
 
Investment grade risk exposure
$
320

$
5

2 years
Corporate Credit/
Foreign Gov.
BBB+
$
247

$
(5
)
Below investment grade risk exposure
29


2 years
Corporate Credit
BB
29

(1
)
Basket credit default swaps [4]
 
 
 
 
 
 
 
Investment grade risk exposure
2,546

33

3 years
Corporate Credit
BBB
1,973

(25
)
Below investment grade risk exposure
38

(1
)
12 years
Corporate Credit
D


Investment grade risk exposure
722

(12
)
6 years
CMBS Credit
AA+
269

3

Below investment grade risk exposure
154

(22
)
2 years
CMBS Credit
CCC+
154

23

Embedded credit derivatives
 
 
 
 
 
 
 
Investment grade risk exposure
350

342

2 years
Corporate Credit
A


Total [5]
$
4,159

$
345

 
 
 
$
2,672

$
(5
)
[1]
The average credit ratings are based on availability and the midpoint of the applicable ratings among Moody’s, S&P, Fitch and Morningstar. If no rating is available from a rating agency, then an internally developed rating is used.
[2]
Notional amount is equal to the maximum potential future loss amount. These derivatives are governed by agreements, clearing house rules and applicable law which include collateral posting requirements. There is no additional specific collateral related to these contracts or recourse provisions included in the contracts to offset losses.
[3]
The Company has entered into offsetting credit default swaps to terminate certain existing credit default swaps, thereby offsetting the future changes in value of, or losses paid related to, the original swap.
[4]
Includes $3.8 billion and $3.5 billion as of March 31, 2015 and December 31, 2014, respectively, of standard market indices of diversified portfolios of corporate and CMBS issuers referenced through credit default swaps. These swaps are subsequently valued based upon the observable standard market index.
[5]
Excludes investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 4 - Fair Value Measurements.